Publicacions
-
Zhang M, Bagán A, Martínez D, Barroso E, Palomer FX, Vázquez S, Escolano C and Vazquez M.
Design and Synthesis of AMPK Activators and GDF15 Inducers
Molecules . 28(14): .
-
Barroso E, Montori M, Wahli W, Palomer FX and Vazquez M.
Striking a gut-liver balance for the antidiabetic effects of metformin
TRENDS IN PHARMACOLOGICAL SCIENCES . 44(7): 457-473. Nº de cites: 5
-
Aguilar-Recarte D, Barroso E, Zhang M, Rada P, Pizarro J, Peña L, Palomer FX, Valverde ÁM, Wahli W and Vazquez M.
A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
PHARMACOLOGICAL RESEARCH . 187: 106578-106578. Nº de cites: 17
-
Aguilar-Recarte D, Barroso E, Palomer FX, Wahli W and Vazquez M.
Knocking on GDF15?s door for the treatment of type 2 diabetes mellitus
TRENDS IN ENDOCRINOLOGY AND METABOLISM . 33(11): 741-754. Nº de cites: 19
-
Montori M, Aguilar-Recarte D, Zarei M, Pizarro J, Palomer FX and Vazquez M.
Endoplasmic reticulum stress downregulates PGC-1a in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2
CELL COMMUNICATION AND SIGNALING . 20(1): 53-53. Nº de cites: 12
-
Aguilar-Recarte D, Barroso E, Gumá L, Pizarro J, Peña L, Ruart M, Palomer FX, Wahli W and Vazquez M.
GDF15 mediates the metabolic effects of PPARß/d by activating AMPK.
CELL REPORTS . 36(6): 109501-109501. Nº de cites: 53
-
Aguilar-Recarte D, Palomer FX, Wahli W and Vazquez M.
The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(16): 8555. Nº de cites: 20
-
Palomer FX, Aguilar-Recarte D, García R, Nistal JF and Vazquez M.
Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.
TRENDS IN MOLECULAR MEDICINE . 27(6): 554-571. Nº de cites: 29
-
Aguilar-Recarte D, Palomer FX and Vazquez M.
Uncovering the role of apolipoprotein C-III in insulin resistance
Clinica e Investigacion en Arteriosclerosis . 33(2): 108-115. Nº de cites: 4
-
Zarei M, Aguilar-Recarte D, Palomer FX and Vazquez M.
Revealing the role of peroxisome proliferator-activated receptor beta/delta in nonalcoholic fatty liver disease
METABOLISM-CLINICAL AND EXPERIMENTAL . 114: 154342-154342. Nº de cites: 32